225 related articles for article (PubMed ID: 31878027)
1. MDA-9/Syntenin (SDCBP) Is a Critical Regulator of Chemoresistance, Survival and Stemness in Prostate Cancer Stem Cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Windle JJ; Sarkar D; Fisher PB
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878027
[TBL] [Abstract][Full Text] [Related]
2. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
3. Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin.
Talukdar S; Pradhan AK; Bhoopathi P; Shen XN; August LA; Windle JJ; Sarkar D; Furnari FB; Cavenee WK; Das SK; Emdad L; Fisher PB
Autophagy; 2018; 14(10):1845-1846. PubMed ID: 30118375
[TBL] [Abstract][Full Text] [Related]
4. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
Das SK; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Sarkar D; Emdad L; Fisher PB
Cancer Res; 2018 Jun; 78(11):2852-2863. PubMed ID: 29572229
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response.
Yan J; Tang D
Exp Cell Res; 2014 Oct; 328(1):132-142. PubMed ID: 25149681
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Notch pathway enhances the anti-tumor effect of docetaxel in prostate cancer stem-like cells.
Wang L; Zi H; Luo Y; Liu T; Zheng H; Xie C; Wang X; Huang X
Stem Cell Res Ther; 2020 Jun; 11(1):258. PubMed ID: 32586404
[TBL] [Abstract][Full Text] [Related]
7. NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells.
Liu C; Li Z; Bi L; Li K; Zhou B; Xu C; Huang J; Xu K
Mol Cell Biochem; 2014 Aug; 393(1-2):265-70. PubMed ID: 24782036
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
[TBL] [Abstract][Full Text] [Related]
10. SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation.
Mir C; Garcia-Mayea Y; Garcia L; Herrero P; Canela N; Tabernero R; Lorente J; Castellvi J; Allonca E; García-Pedrero J; Rodrigo JP; Carracedo Á; LLeonart ME
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638436
[TBL] [Abstract][Full Text] [Related]
11. MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells.
Talukdar S; Pradhan AK; Bhoopathi P; Shen XN; August LA; Windle JJ; Sarkar D; Furnari FB; Cavenee WK; Das SK; Emdad L; Fisher PB
Proc Natl Acad Sci U S A; 2018 May; 115(22):5768-5773. PubMed ID: 29760085
[TBL] [Abstract][Full Text] [Related]
12. Metabolic characterization of sphere-derived prostate cancer stem cells reveals aberrant urea cycle in stemness maintenance.
Luo Y; Yu J; Lin Z; Wang X; Zhao J; Liu X; Qin W; Xu G
Int J Cancer; 2024 Apr; ():. PubMed ID: 38647131
[TBL] [Abstract][Full Text] [Related]
13. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
14. Circadian Rhythm Gene PER3 Negatively Regulates Stemness of Prostate Cancer Stem Cells via WNT/β-Catenin Signaling in Tumor Microenvironment.
Li Q; Xia D; Wang Z; Liu B; Zhang J; Peng P; Tang Q; Dong J; Guo J; Kuang D; Chen W; Mao J; Li Q; Chen X
Front Cell Dev Biol; 2021; 9():656981. PubMed ID: 33816508
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase.
Sarveswaran S; Varma NRS; Morisetty S; Ghosh J
Oncotarget; 2019 Jan; 10(4):424-436. PubMed ID: 30728896
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
17. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
Pradhan AK; Maji S; Das SK; Emdad L; Sarkar D; Fisher PB
Cancer Metastasis Rev; 2020 Sep; 39(3):769-781. PubMed ID: 32410111
[TBL] [Abstract][Full Text] [Related]
18. AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification.
Wang H; Liu J; Zhu X; Yang B; He Z; Yao X
Research (Wash D C); 2023; 6():0252. PubMed ID: 37854295
[TBL] [Abstract][Full Text] [Related]
19. Signaling Pathways and Targeted Therapies for Stem Cells in Prostate Cancer.
Giridharan M; Rupani V; Banerjee S
ACS Pharmacol Transl Sci; 2022 Apr; 5(4):193-206. PubMed ID: 35434534
[TBL] [Abstract][Full Text] [Related]
20. Insights into Chemoresistance of Prostate Cancer.
Zhang W; Meng Y; Liu N; Wen XF; Yang T
Int J Biol Sci; 2015; 11(10):1160-70. PubMed ID: 26327810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
